new med for type 2 diabetes, Avandia (rosiglitazone)

There's now a new med for type 2 diabetes, Avandia (rosiglitazone)...from SmithKline Beecham and Bristol-Myers Squibb.

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

All three lower blood glucose by improving insulin sensitivity.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote